Newsletter | October 21, 2026

10.21.26 -- Beyond GalNAc: Reengineering siRNA For Extrahepatic Delivery

SPONSOR

 

Webinar: Connecting the World of Oligonucleotide R&D With Early Clinical Scale Manufacturing

Moving oligonucleotide production from R&D to early clinical manufacturing brings new challenges in quality, scalability, process development, and equipment. This webinar explores a requirements-driven approach to oligonucleotide manufacturing, from solid-phase synthesis through scale-up, and highlights advances in synthesizer technology. Gain practical insights into building robust, reproducible processes that support pharmaceutical development and manufacturing at clinical scale. Click here to learn more.

FEATURED EDITORIAL

How Advanced Manufacturing Technologies Are Accelerating Innovation

From a tech perspective, the manufacturing objective is shifting toward integrated process optimization. Automated reaction control, multivariate analytics, and more can connect molecular quality with operational performance. 

 

Engineering CAR T Cells With mRNA-LNPs: Applying Oncology Learnings To Allergic Diseases

Targeted lipid nanoparticles (LNPs) could deliver mRNA encoding a CAR directly to T cells inside a patient with allergic disease. The potential implications extend beyond a single allergic condition. 

 

Beyond GalNAc: Reengineering siRNA For Extrahepatic Delivery

We discuss why effective extrahepatic delivery remains one of the field's biggest obstacles and how chemical engineering may provide a new path forward.

 

Is The mRNA Industry Aligned Around LNP CQAs?

In this Advancing RNA Live clip, panelists Ilya Shestopalov, Philippe Talaga, and Elaine Peters share their perspectives on how aligned around our DP CQAs we are from a company and regulatory standpoint, and where specifically misalignments are revealing themselves today. 

 

INDUSTRY INSIGHTS

 

Scaling Manufacturing Flexibility For Fill/Finish Commercial Success

Pharma and biotech developers rely on adaptable fill/finish capacity to meet evolving market demands, scale products from clinical to commercial, and respond rapidly to public‑health emergencies.

 

Solvent-Free Purification Of D84-mer Oligonucleotide Using Resin

Discover a solvent-free process using resins. They enable high-purity, scalable purification of long oligonucleotides, achieving more than 95% of full-length product purity.

 

Pushing The Boundaries Of Chromatographic Separation

Metal-sensitive analytes often suffer from poor recovery and distorted peak shapes. Learn how inert hardware improves sensitivity and chromatographic performance for challenging analyses.

 

The Bioanalysis Report You Actually Get Back Fast

Manual bioanalysis variability creates data noise. Automation replaces inconsistencies with repeatable processes that boost precision, support compliance, and deliver more reliable results.

 

Next Generation Sequencing In Viral Safety Testing

Next Generation Sequencing offers a sensitive, high-throughput solution for detecting adventitious viral agents, improving safety and accelerating regulatory-compliant product development.

 

The Next Generation Of mRNA Products: Implications For Quality Control

To fully realize the potential of mRNA as a therapeutic or vaccine modality, developers will need to employ cutting-edge analytical methods to ensure the safety and efficacy of these novel products.

SOLUTIONS

Vaccinia Capping System mRNA Guanylyltransferase And Methyltransferase

mRNA Therapeutics: Development And cGMP Manufacturing

Advancing Genomic Medicines From Discovery To Commericalization

mRNA Capabilities